More than 70 faculty from Weill Cornell Medicine, Cornell Engineering and Cornell Tech assembled Oct. 1 at the Statler Ballroom — and more joined remotely — to kick off the Cornell Engineering Innovations in Medicine initiative.
The psychedelic drugs LSD and psilocybin activate serotonin receptors on brain cells in a way that reduces the energy needed for the brain to switch between different activity states, according to a study led by Weill Cornell Medicine researchers.
The presence of some fungal species in tumors predicts – and may even help drive – worse cancer outcomes, according to a study from Weill Cornell Medicine and Duke University researchers.
A new Cornell research project aims to gain a better understanding of how populations of microbes interact on surface environments, such as human skin, where their dynamics are not fully understood.
As doctoral students nearly 20 years ago, two Cornell researchers played an early role in the development of the work that was awarded the 2022 Nobel Prize in chemistry.
By analyzing key enzymes in a new way, an international team led by researchers at Weill Cornell Medicine has discovered how a well-known signaling molecule can either stimulate or suppress tumor growth depending on where it’s produced.
David Reetz, director of counseling and psychological services at the Rochester Institute of Technology, has been named Cornell’s new director of Counseling and Psychological Services; he will join Cornell in mid-December.
